NL8402769A - 1-heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl piperazinederivaten; werkwijze voor het bereiden daarvan; farmaceutische preparaten. - Google Patents

1-heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl piperazinederivaten; werkwijze voor het bereiden daarvan; farmaceutische preparaten. Download PDF

Info

Publication number
NL8402769A
NL8402769A NL8402769A NL8402769A NL8402769A NL 8402769 A NL8402769 A NL 8402769A NL 8402769 A NL8402769 A NL 8402769A NL 8402769 A NL8402769 A NL 8402769A NL 8402769 A NL8402769 A NL 8402769A
Authority
NL
Netherlands
Prior art keywords
formula
compound
pharmaceutically acceptable
hydrogen
condensed
Prior art date
Application number
NL8402769A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8402769A publication Critical patent/NL8402769A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/54—Preparation of carboxylic acid anhydrides
    • C07C51/56—Preparation of carboxylic acid anhydrides from organic acids, their salts, their esters or their halides, e.g. by carboxylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/39—Unsaturated compounds containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8402769A 1983-09-12 1984-09-11 1-heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl piperazinederivaten; werkwijze voor het bereiden daarvan; farmaceutische preparaten. NL8402769A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53151983 1983-09-12
US06/531,519 US4524206A (en) 1983-09-12 1983-09-12 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives

Publications (1)

Publication Number Publication Date
NL8402769A true NL8402769A (nl) 1985-04-01

Family

ID=24117966

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8402769A NL8402769A (nl) 1983-09-12 1984-09-11 1-heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl piperazinederivaten; werkwijze voor het bereiden daarvan; farmaceutische preparaten.

Country Status (33)

Country Link
US (1) US4524206A (sv)
JP (1) JPH0647586B2 (sv)
KR (1) KR890000566B1 (sv)
AR (1) AR241910A1 (sv)
AU (1) AU581858B2 (sv)
BE (1) BE900555A (sv)
CA (1) CA1285564C (sv)
CH (1) CH660484A5 (sv)
CS (1) CS258119B2 (sv)
CY (1) CY1538A (sv)
DD (1) DD224593A5 (sv)
DE (1) DE3433327C2 (sv)
DK (1) DK171990B1 (sv)
ES (1) ES8605797A1 (sv)
FI (1) FI83515C (sv)
FR (1) FR2555585B1 (sv)
GB (1) GB2146333B (sv)
GR (1) GR80320B (sv)
HK (1) HK84590A (sv)
HU (1) HU192439B (sv)
IE (1) IE58020B1 (sv)
IL (1) IL72854A (sv)
IT (1) IT1196250B (sv)
LU (1) LU85537A1 (sv)
NL (1) NL8402769A (sv)
NO (1) NO162384B (sv)
NZ (1) NZ209480A (sv)
OA (1) OA07809A (sv)
PT (1) PT79187B (sv)
SE (1) SE463368B (sv)
SU (1) SU1384199A3 (sv)
YU (2) YU45655B (sv)
ZA (1) ZA847065B (sv)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4585773A (en) * 1984-07-11 1986-04-29 Bristol-Myers Company Isoindolinyl-alkyl-piperazines
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
JPS61238784A (ja) * 1985-04-17 1986-10-24 Sumitomo Seiyaku Kk コハク酸イミド誘導体及びその酸付加塩
US4656173A (en) * 1985-04-24 1987-04-07 Bristol-Myers Company Antipsychotic benzisothiazole S-oxide compound
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4826843A (en) * 1985-07-08 1989-05-02 Bristol-Myers Cerebral function enhancing diazinylpiperidine derivatives
NZ216720A (en) * 1985-07-08 1990-09-26 Bristol Myers Co Diazinylpiperidine derivatives and pharmaceutical compositions
US4925841A (en) * 1985-07-22 1990-05-15 Temple University Of The Commonwealth System Of Higher Education Mannich bases of spirosuccinimides
JP2660407B2 (ja) * 1986-09-26 1997-10-08 住友製薬株式会社 新規なイミド誘導体
US4757073A (en) * 1986-09-30 1988-07-12 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use
DD263531A5 (de) * 1986-10-21 1989-01-04 ������@���Kk�� Verfahren zur herstellung von verbrueckten bicyclischen imidverbindungen
US4777254A (en) * 1986-12-02 1988-10-11 American Home Products Corp. Cyclic imides as H1 -antagonists
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US4855430A (en) * 1987-11-12 1989-08-08 American Home Products Corporation Polycyclicamine with psychotropic activity
EP0348460A4 (en) * 1987-11-12 1991-11-27 American Home Products Corporation Polycyclicamines with psychotropic activity
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
NZ230045A (en) 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
HUT61760A (en) * 1988-09-16 1993-03-01 Pfizer Process for producing bridged, bicyclic imides comprising 4-/4-(3-benzisothiazolyl)-1-piperazinyl/-butyl group and pharmaceutical compositions comprising such compounds
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
US5098904A (en) * 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
CN1050604C (zh) * 1993-02-04 2000-03-22 明治制果株式会社 具有抗精神病作用的化合物
US5338738A (en) * 1993-04-19 1994-08-16 Bristol-Myers Squibb Company Cerebral function enhancers: acyclic amide derivatives of pyrimidinylpiperidines
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .
US5538985A (en) * 1994-01-27 1996-07-23 Mitsui Toatsu Chemicals, Inc. Pyrrolidinone derivatives
US5521313A (en) * 1994-05-05 1996-05-28 Bristol-Myers Squibb Company Process for preparing certain azapirones
US6084097A (en) * 1997-10-20 2000-07-04 Council Of Scientific & Industrial Research Methods for preparing 1-[4-arylpiperazin-1-yl]-3-[2-oxopyrrolidin/piperidin-1-yl] propanes
US6083950A (en) * 1997-11-13 2000-07-04 Ranbaxy Laboratories Limited 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers
EP1243609B1 (en) * 1999-12-27 2007-10-24 Idemitsu Kosan Co., Ltd. Succinimide compounds and use thereof
CN1230423C (zh) 2000-11-30 2005-12-07 兰贝克赛实验室有限公司 可有效用作尿－选择性α1－肾上腺素能受体封阻剂的1,4－双取代的哌嗪衍生物
US6660736B2 (en) * 2002-03-27 2003-12-09 Hoffmann-La Roche Inc. Phthalimido derivatives and a process for their preparation
US20050228180A1 (en) * 2002-04-08 2005-10-13 Mohammad Salman Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
DE602004017206D1 (de) * 2003-10-23 2008-11-27 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
EP1758583A2 (en) * 2004-05-31 2007-03-07 Ranbaxy Laboratories Limited Arylpiperazine derivatives useful as adrenergic receptor antagonists
US20060247249A1 (en) * 2005-11-16 2006-11-02 Mohammad Salman Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers
AU2007221214A1 (en) 2006-02-22 2007-09-07 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US7858790B2 (en) 2006-06-29 2010-12-28 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP2159226B1 (de) * 2007-03-29 2016-08-31 Joint-stock Company "Obninsk Chemical Pharmaceutical Company" Antihistamin- und antiallergienmittel sowie verfahren zu seiner herstellung
BR112013008063A2 (pt) 2010-10-05 2016-06-14 Syngenta Participations Ag pirrolidin-il-aril-carboxamidas inseticidas
AR086587A1 (es) 2011-05-31 2014-01-08 Syngenta Participations Ag Compuestos insecticidas
CN109438316A (zh) 2011-10-03 2019-03-08 先正达参股股份有限公司 杀虫的3-芳基-3-三氟甲基-取代的吡咯烷的对映选择性方法
EP3896058A3 (en) 2011-10-03 2022-01-12 Syngenta Participations Ag Enantionselective processes to insecticidal 3-aryl-3-trifluoromethyl-substituted pyrrolidines
EP3601275A1 (en) 2017-03-23 2020-02-05 Syngenta Participations AG Insecticidal compounds
WO2018172480A1 (en) 2017-03-23 2018-09-27 Syngenta Participations Ag Insecticidal compounds
WO2019243263A1 (en) 2018-06-19 2019-12-26 Syngenta Participations Ag Insecticidal compounds
EP3856715A1 (en) 2018-09-26 2021-08-04 Syngenta Participations Ag Insecticidal compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
US3558777A (en) * 1968-06-21 1971-01-26 Mead Johnson & Co Pharmacologic processes and compositions containing azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4305944A (en) * 1980-09-08 1981-12-15 Mead Johnson & Company N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
KR850002483A (ko) 1985-05-13
KR890000566B1 (ko) 1989-03-21
DK433884D0 (da) 1984-09-12
DK433884A (da) 1985-03-13
ES535780A0 (es) 1986-04-01
ZA847065B (en) 1985-04-24
IL72854A0 (en) 1984-12-31
FR2555585A1 (fr) 1985-05-31
DK171990B1 (da) 1997-09-08
YU210386A (en) 1987-12-31
CY1538A (en) 1990-11-16
YU45655B (sh) 1992-07-20
IT8422621A0 (it) 1984-09-11
DE3433327C2 (de) 1998-07-16
FR2555585B1 (fr) 1989-01-06
GB8422860D0 (en) 1984-10-17
SE8404552L (sv) 1985-03-13
SU1384199A3 (ru) 1988-03-23
NZ209480A (en) 1988-01-08
YU45809B (sh) 1992-07-20
LU85537A1 (fr) 1985-04-29
PT79187A (en) 1984-10-01
PT79187B (en) 1986-11-24
SE463368B (sv) 1990-11-12
HU192439B (en) 1987-06-29
JPS6084282A (ja) 1985-05-13
IE58020B1 (en) 1993-06-30
GB2146333B (en) 1987-04-01
IL72854A (en) 1988-03-31
AU3287084A (en) 1985-05-30
HK84590A (en) 1990-10-25
US4524206A (en) 1985-06-18
DE3433327A1 (de) 1985-03-28
AR241910A1 (es) 1993-01-29
NO843579L (no) 1985-03-13
DD224593A5 (de) 1985-07-10
IE842311L (en) 1985-03-12
CA1285564C (en) 1991-07-02
GB2146333A (en) 1985-04-17
CH660484A5 (de) 1987-04-30
HUT36116A (en) 1985-08-28
ES8605797A1 (es) 1986-04-01
FI83515B (fi) 1991-04-15
FI83515C (sv) 1991-07-25
FI843522A0 (fi) 1984-09-07
JPH0647586B2 (ja) 1994-06-22
FI843522L (fi) 1985-03-13
CS258119B2 (en) 1988-07-15
YU156384A (en) 1987-02-28
GR80320B (en) 1985-01-14
NO162384B (no) 1989-09-11
OA07809A (fr) 1986-11-20
BE900555A (fr) 1985-03-11
CS672184A2 (en) 1987-12-17
AU581858B2 (en) 1989-03-09
SE8404552D0 (sv) 1984-09-11
IT1196250B (it) 1988-11-16

Similar Documents

Publication Publication Date Title
NL8402769A (nl) 1-heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl piperazinederivaten; werkwijze voor het bereiden daarvan; farmaceutische preparaten.
NL193283C (nl) 4,4-Dialkyl-1-[4-[4-(2-pirimidinyl)-1-piperazinyl]-butyl]-2,6- piperazinedionen.
CH649539A5 (de) Antidepressiv wirksame piperazinylalkyl-1,2,4-triazol-3-one.
EP3480199A1 (en) Imidazopyridinamine phenyl derivative and use thereof
SU1442074A3 (ru) Способ получени производных @ -карболина или их фармацевтически приемлемых солей
HU190827B (en) Process for preparing 2-/4/-/4,4-dialkyl-1,2,6-piperidindion-1-yl/-butyl/-1-piperazinyl/-pyridines
US20130102627A1 (en) Acridines As Inhibitors Of Haspin And DYRK Kinases
JPS6053014B2 (ja) 薬理作用を有するピリジン誘導体
FI89915B (fi) Foerfarande foer framstaellning av psykotropiska acykliska amidderivat
JPH0134226B2 (sv)
Dey et al. Synthesis and properties of fluorine‐containing heterocyclic compounds. I. trifluoromethyl quinolines
KR20020011986A (ko) 5-치환된 아릴피리미딘
JPH02115166A (ja) ピリジルケトオキシムエーテル誘導体
JPH03181473A (ja) 複素環式化合物、その製造方法、これを含有する心臓血管障害の治療用の医薬およびその製造のための中間体
FI82456B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-fenyl-1,2,4-tiadiazin-1-oxidderivat.
CA2396560A1 (en) Tricyclic compounds and method of treating herpes virus
NL8203035A (nl) Spirothiazolidinylpiperazinederivaten.
Acosta Quintero et al. Similar molecular constitutions but different conformations and different supramolecular assemblies in two related fused tetracyclic benzo [b] pyrimido [5, 4-f] azepine derivatives
FR2616433A1 (fr) Nouveaux derives piperazinyl alkyl piperazine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US20130102677A1 (en) Novel solid forms of tacedinaline
Kulshrestha et al. Multifarious stage synthesis of uniquely substituted Chromeno derivatives of carboxy and amino pyrimidine
AT387773B (de) Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
JPS61205260A (ja) 新規な２−置換アミノ−６−（２−メトキシフエニ−ル）−４（３ｈ）−ピリミドン誘導体及びその製造法
TWI261590B (en) C-6 ring-substituted pyrido [1,2-a]benzimidazole derivatives useful in treating central nervous system disorders
CS258133B2 (cs) Způsob výroby l-heteroaryl-4-[(2,5-pyrrolidindion-l-yl)alkyl]- piperazinových derivátů

Legal Events

Date Code Title Description
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable